Abstract
Phage therapy is revolving to address the issues mainly dealing with antibiotic resistance in the pathogenic bacteria. Among the drug-resistant microbial populations, the bacterial species have been categorized as high-priority or critical-priority bacteria. This review summarizes the efficiency and development in phage therapy used against these drug-resistant bacteria in the past few years mainly belonging to the critical- and high-priority list. Phage therapy is more than just an alternative to antibiotics as it not only kills the target microbial population directly but also leads to the chemical and physical modifications in bacterial cell structures. These phage-mediated modifications in the bacterial cell may make them antibiotic sensitive. Application of phage therapy in antibiotic-resistant foodborne bacteria and possible modulation in gut microbes has also been explored. Further, the phage cocktail antibiotic formulation, containing more than one type of phage with antibiotics, has also been discussed.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Data Availability
All data are obtained from publicly available information.
References
Abdel-Haliem, M. E., & Askora, A. (2013). Isolation and characterization of bacteriophages of Helicobacter pylori isolated from Egypt. Future Virology, 8(8), 821–826. https://doi.org/10.2217/fvl.13.58
Al-Zubidi, M., Widziolek, M., Court, E. K., Gains, A. F., Smith, R. E., Ansbro, K., et al. (2019). Identification of novel bacteriophages with therapeutic potential that target Enterococcus faecalis. Infection and Immunity. https://doi.org/10.1128/IAI.00512-19
Amarillas, L., Rubí-Rangel, L., Chaidez, C., González-Robles, A., Lightbourn-Rojas, L., & León-Félix, J. (2017). Isolation and characterization of phiLLS, a novel phage with potential biocontrol agent against multidrug-resistant Escherichia coli. Frontiers in Microbiology. https://doi.org/10.3389/fmicb.2017.01355
Aslam, S., Courtwright, A. M., Koval, C., Lehman, S. M., Morales, S., Furr, C. L. L., et al. (2019). Early clinical experience of bacteriophage therapy in 3 lung transplant recipients. American Journal of Transplantation, 19(9), 2631–2639.
Azam, A. H., & Tanji, Y. (2019). Bacteriophage-host arm race: An update on the mechanism of phage resistance in bacteria and revenge of the phage with the perspective for phage therapy. Applied Microbiology and Biotechnology, 103(5), 2121–2131. https://doi.org/10.1007/s00253-019-09629-x
Banin, E., Hughes, D., & Kuipers, O. P. (2017). Editorial: Bacterial pathogens, antibiotics and antibiotic resistance. FEMS Microbiology Reviews, 41(3), 450–452. https://doi.org/10.1093/femsre/fux016
Bao, H., Zhou, Y., Shahin, K., Zhang, H., Cao, F., Pang, M., et al. (2020a). The complete genome of lytic Salmonella phage vB_SenM-PA13076 and therapeutic potency in the treatment of lethal Salmonella Enteritidis infections in mice. Microbiological Research. https://doi.org/10.1016/j.micres.2020.126471
Bao, J., Wu, N., Zeng, Y., Chen, L., Li, L., Yang, L., et al. (2020b). Non-active antibiotic and bacteriophage synergism to successfully treat recurrent urinary tract infection caused by extensively drug-resistant Klebsiella pneumoniae. Emerging Microbes & Infections, 9(1), 771–774. https://doi.org/10.1080/22221751.2020.1747950
Barr, J. J. (2017). A bacteriophages journey through the human body. Immunological Reviews, 279(1), 106–122. https://doi.org/10.1111/imr.12565
Bodner, K., Melkonian, A. L., & Covert, M. W. (2020). The enemy of my enemy: New insights regarding bacteriophage-mammalian cell interactions. Trends in Microbiology. https://doi.org/10.1016/j.tim.2020.10.014
Canfield, G. S., Chatterjee, A., Espinosa, J., Mangalea, M. R., Sheriff, E. K., Keidan, M., et al. (2021). Lytic bacteriophages facilitate antibiotic sensitization of Enterococcus faecium. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/AAC.00143-21
Carrigy, N. B., Liang, L., Wang, H., Kariuki, S., Nagel, T. E., Connerton, I. F., & Vehring, R. (2019). Spray-dried anti-Campylobacter bacteriophage CP30A powder suitable for global distribution without cold chain infrastructure. International Journal of Pharmaceutics, 569, 118601. https://doi.org/10.1016/j.ijpharm.2019.118601
Chan, B. K., Sistrom, M., Wertz, J. E., Kortright, K. E., Narayan, D., & Turner, P. E. (2016). Phage selection restores antibiotic sensitivity in MDR Pseudomonas aeruginosa. Scientific Reports, 6(1), 26717. https://doi.org/10.1038/srep26717
Chan, B. K., Turner, P. E., Kim, S., Mojibian, H. R., Elefteriades, J. A., & Narayan, D. (2018). Phage treatment of an aortic graft infected with Pseudomonas aeruginosa. Evolution, Medicine, and Public Health, 2018(1), 60–66. https://doi.org/10.1093/emph/eoy005
Cheng, M., Liang, J., Zhang, Y., Hu, L., Gong, P., Cai, R., et al. (2017a). The bacteriophage EF-P29 efficiently protects against lethal vancomycin-resistant Enterococcus faecalis and alleviates gut microbiota imbalance in a murine bacteremia model. Frontiers in Microbiology. https://doi.org/10.3389/fmicb.2017.00837
Cheng, M., Zhang, Y., Li, X., Liang, J., Hu, L., Gong, P., et al. (2017b). Endolysin LysEF-P10 shows potential as an alternative treatment strategy for multidrug-resistant Enterococcus faecalis infections. Scientific Reports, 7(1), 10164. https://doi.org/10.1038/s41598-017-10755-7
Chhibber, S., Shukla, A., & Kaur, S. (2017). Transfersomal phage cocktail is an effective treatment against methicillin-resistant Staphylococcus aureus-mediated skin and soft tissue infections. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/AAC.02146-16
Cieślik, M., Bagińska, N., Górski, A., & Jończyk-Matysiak, E. (2021). Animal models in the evaluation of the effectiveness of phage therapy for infections caused by Gram-negative bacteria from the ESKAPE group and the reliability of its use in humans. Microorganisms, 9(2), 206. https://doi.org/10.3390/microorganisms9020206
Clavijo, V., Baquero, D., Hernandez, S., Farfan, J. C., Arias, J., Arévalo, A., et al. (2019). Phage cocktail SalmoFREE® reduces Salmonella on a commercial broiler farm. Poultry Science, 98(10), 5054–5063. https://doi.org/10.3382/ps/pez251
Colavecchio, A., Cadieux, B., Lo, A., & Goodridge, L. D. (2017). Bacteriophages contribute to the spread of antibiotic resistance genes among foodborne pathogens of the enterobacteriaceae family—A review. Frontiers in Microbiology. https://doi.org/10.3389/fmicb.2017.01108
Colom, J., Batista, D., Baig, A., Tang, Y., Liu, S., Yuan, F., et al. (2019). Sex pilus specific bacteriophage to drive bacterial population towards antibiotic sensitivity. Scientific Reports, 9(1), 12616. https://doi.org/10.1038/s41598-019-48483-9
Corbellino, M., Kieffer, N., Kutateladze, M., Balarjishvili, N., Leshkasheli, L., Askilashvili, L., et al. (2020). Eradication of a multidrug-resistant, carbapenemase-producing klebsiella pneumoniae isolate following oral and intra-rectal therapy with a custom made lytic bacteriophage preparation. Clinical Infectious Diseases, 70(9), 1998–2001. https://doi.org/10.1093/cid/ciz782
Easwaran, M., De Zoysa, M., & Shin, H. (2020). Application of phage therapy: Synergistic effect of phage EcSw (ΦEcSw) and antibiotic combination towards antibiotic-resistant Escherichia coli. Transboundary and Emerging Diseases, 67(6), 2809–2817. https://doi.org/10.1111/tbed.13646
El-Shibiny, A., Scott, A., Timms, A., Metawea, Y., Connerton, P., & Connerton, I. (2009). Application of a group II campylobacter bacteriophage to reduce strains of Campylobacter jejuni and Campylobacter coli colonizing broiler chickens. Journal of Food Protection, 72(4), 733–740. https://doi.org/10.4315/0362-028X-72.4.733
El Haddad, L., Harb, C. P., Gebara, M. A., Stibich, M. A., & Chemaly, R. F. (2019). A Systematic and critical review of bacteriophage therapy against multidrug-resistant ESKAPE organisms in humans. Clinical Infectious Diseases, 69(1), 167–178. https://doi.org/10.1093/cid/ciy947
Fish, R., Kutter, E., Wheat, G., Blasdel, B., Kutateladze, M., & Kuhl, S. (2018). Compassionate use of bacteriophage therapy for foot ulcer treatment as an effective step for moving toward clinical trials. Methods in Molecular Biology, 1693, 159–170. https://doi.org/10.1007/978-1-4939-7395-8_14
Gabashvili, E., Kobakhidze, S., Koulouris, S., Robinson, T., & Kotetishvili, M. (2021). Bi- and multi-directional gene transfer in the natural populations of polyvalent bacteriophages, and their host species spectrum representing foodborne versus other human and/or animal pathogens. Food and Environmental Virology. https://doi.org/10.1007/s12560-021-09460-6
Gainey, A. B., Burch, A., Brownstein, M. J., Brown, D. E., Fackler, J., Horne, B., et al. (2020). Combining bacteriophages with cefiderocol and meropenem/vaborbactam to treat a pan-drug resistant Achromobacter species infection in a pediatric cystic fibrosis patient. Pediatric Pulmonology, 55(11), 2990–2994. https://doi.org/10.1002/ppul.24945
Grygorcewicz, B., Wojciuk, B., Roszak, M., Łubowska, N., Blstrokaejczak, P., Jursa-Kulesza, J., et al. (2021). Environmental phage-based cocktail and antibiotic combination effects on Acinetobacter baumannii biofilm in a human urine model. Microbial Drug Resistance, 27(1), 25–35. https://doi.org/10.1089/mdr.2020.0083
Hankin, E. H. (1896). L’action bactericide des eaux de la Jumna et du Gange sur le vibrion du cholera. In Annales de l’Institut Pasteur (Vol. t. 10, p. 790). http://www.biodiversitylibrary.org/item/22126
Hua, Y., Luo, T., Yang, Y., Dong, D., Wang, R., Wang, Y., et al. (2018). Phage therapy as a promising new treatment for lung infection caused by carbapenem-resistant Acinetobacter baumannii in mice. Frontiers in Microbiology. https://doi.org/10.3389/fmicb.2017.02659
Huang, C., Virk, S. M., Shi, J., Zhou, Y., Willias, S. P., Morsy, M. K., et al. (2018). Isolation, characterization, and application of bacteriophage LPSE1 against Salmonella enterica in ready to eat (RTE) Foods. Frontiers in Microbiology. https://doi.org/10.3389/fmicb.2018.01046
Iwano, H., Inoue, Y., Takasago, T., Kobayashi, H., Furusawa, T., Taniguchi, K., et al. (2018). Bacteriophage ΦSA012 has a broad host range against Staphylococcus aureus and effective lytic capacity in a mouse mastitis model. Biology, 7(1), 8. https://doi.org/10.3390/biology7010008
Jamal, M., Andleeb, S., Jalil, F., Imran, M., Nawaz, M. A., Hussain, T., et al. (2019). Isolation, characterization and efficacy of phage MJ2 against biofilm forming multi-drug resistant Enterobacter cloacae. Folia Microbiologica, 64(1), 101–111. https://doi.org/10.1007/s12223-018-0636-x
Jansen, M., Wahida, A., Latz, S., Krüttgen, A., Häfner, H., Buhl, E. M., et al. (2018). Enhanced antibacterial effect of the novel T4-like bacteriophage KARL-1 in combination with antibiotics against multi-drug resistant Acinetobacter baumannii. Scientific Reports, 8(1), 14140. https://doi.org/10.1038/s41598-018-32344-y
Jault, P., Leclerc, T., Jennes, S., Pirnay, J. P., Que, Y. A., Resch, G., et al. (2019). Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): A randomised, controlled, double-blind phase 1/2 trial. The Lancet Infectious Diseases, 19(1), 35–45. https://doi.org/10.1016/S1473-3099(18)30482-1
Jeon, J., Park, J.-H., & Yong, D. (2019). Efficacy of bacteriophage treatment against carbapenem-resistant Acinetobacter baumannii in Galleria mellonella larvae and a mouse model of acute pneumonia. BMC Microbiology, 19(1), 70. https://doi.org/10.1186/s12866-019-1443-5
Kabwe, M., Meehan-Andrews, T., Ku, H., Petrovski, S., Batinovic, S., Chan, H. T., & Tucci, J. (2021). Lytic bacteriophage EFA1 Modulates HCT116 colon cancer cell growth and upregulates ROS production in an Enterococcus faecalis co-culture system. Frontiers in Microbiology. https://doi.org/10.3389/fmicb.2021.650849
Kakabadze, E., Makalatia, K., Grdzelishvili, N., Bakuradze, N., Goderdzishvili, M., Kusradze, I., et al. (2018). Selection of potential therapeutic bacteriophages that lyse a CTX-M-15 extended spectrum β-lactamase producing Salmonella enterica Serovar Typhi Strain from the Democratic Republic of the Congo. Viruses, 10(4), 172. https://doi.org/10.3390/v10040172
Kebriaei, R., Lev, K., Morrisette, T., Stamper, K. C., Abdul-Mutakabbir, J. C., Lehman, S. M., et al. (2020). Bacteriophage-antibiotic combination strategy: An alternative against methicillin-resistant phenotypes of Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/AAC.00461-20
Khalifa, L., Gelman, D., Shlezinger, M., Dessal, A. L., Coppenhagen-Glazer, S., Beyth, N., & Hazan, R. (2018). Defeating antibiotic- and phage-resistant Enterococcus faecalis using a phage cocktail in vitro and in a clot model. Frontiers in Microbiology. https://doi.org/10.3389/fmicb.2018.00326
Kim, H. Y., Chang, R. Y. K., Morales, S., & Chan, H.-K. (2021). Bacteriophage-delivering hydrogels: Current progress in combating antibiotic resistant bacterial infection. Antibiotics, 10(2), 130. https://doi.org/10.3390/antibiotics10020130
Kim, M., Jo, Y., Hwang, Y. J., Hong, H. W., Hong, S. S., Park, K., & Myung, H. (2018). Phage-antibiotic synergy via delayed lysis. Applied and Environmental Microbiology. https://doi.org/10.1128/AEM.02085-18
Kwiatek, M., Parasion, S., Rutyna, P., Mizak, L., Gryko, R., Niemcewicz, M., et al. (2017). Isolation of bacteriophages and their application to control Pseudomonas aeruginosa in planktonic and biofilm models. Research in Microbiology, 168(3), 194–207. https://doi.org/10.1016/j.resmic.2016.10.009
Labrie, S. J., Samson, J. E., & Moineau, S. (2010). Bacteriophage resistance mechanisms. Nature Reviews Microbiology, 8(5), 317–327. https://doi.org/10.1038/nrmicro2315
Latz, S., Krüttgen, A., Häfner, H., Buhl, E., Ritter, K., & Horz, H.-P. (2017). Differential effect of newly isolated phages belonging to PB1-like, phiKZ-like and LUZ24-like viruses against multi-drug resistant Pseudomonas aeruginosa under varying growth conditions. Viruses, 9(11), 315. https://doi.org/10.3390/v9110315
Leitner, L., Sybesma, W., Chanishvili, N., Goderdzishvili, M., Chkhotua, A., Ujmajuridze, A., et al. (2017). Bacteriophages for treating urinary tract infections in patients undergoing transurethral resection of the prostate: A randomized, placebo-controlled, double-blind clinical trial. BMC Urology. https://doi.org/10.1186/s12894-017-0283-6
Leitner, L., Ujmajuridze, A., Chanishvili, N., Goderdzishvili, M., Chkonia, I., Rigvava, S., et al. (2021). Intravesical bacteriophages for treating urinary tract infections in patients undergoing transurethral resection of the prostate: A randomised, placebo-controlled, double-blind clinical trial. The Lancet Infectious Diseases, 21(3), 427–436. https://doi.org/10.1016/S1473-3099(20)30330-3
Li, M., Lin, H., Jing, Y., & Wang, J. (2020a). Broad-host-range Salmonella bacteriophage STP4-a and its potential application evaluation in poultry industry. Poultry Science, 99(7), 3643–3654. https://doi.org/10.1016/j.psj.2020.03.051
Li, M., Guo, M., Chen, L., Zhu, C., Xiao, Y., Li, P., et al. (2020b). Isolation and characterization of novel lytic bacteriophages infecting epidemic carbapenem-resistant Klebsiella pneumoniae strains. Frontiers in Microbiology. https://doi.org/10.3389/fmicb.2020.01554
Ma, Y., Wang, C., Li, Y., Li, J., Wan, Q., Chen, J., et al. (2020). Considerations and caveats in combating ESKAPE pathogens against nosocomial infections. Advanced Science, 7(1), 1901872. https://doi.org/10.1002/advs.201901872
Mangalea, M. R., & Duerkop, B. A. (2020). Fitness trade-offs resulting from bacteriophage resistance potentiate synergistic antibacterial strategies. Infection and Immunity. https://doi.org/10.1128/IAI.00926-19
Manohar, P., Tamhankar, A. J., Lundborg, C. S., & Nachimuthu, R. (2019). Therapeutic characterization and efficacy of bacteriophage cocktails infecting Escherichia coli, Klebsiella pneumoniae, and Enterobacter species. Frontiers in Microbiology. https://doi.org/10.3389/fmicb.2019.00574
McCallin, S., Alam Sarker, S., Barretto, C., Sultana, S., Berger, B., Huq, S., et al. (2013). Safety analysis of a Russian phage cocktail: From MetaGenomic analysis to oral application in healthy human subjects. Virology, 443(2), 187–196. https://doi.org/10.1016/j.virol.2013.05.022
Merabishvili, M., Pirnay, J.-P., Verbeken, G., Chanishvili, N., Tediashvili, M., Lashkhi, N., et al. (2009). Quality-controlled small-scale production of a well-defined bacteriophage cocktail for use in human clinical trials. PLoS ONE, 4(3), e4944. https://doi.org/10.1371/journal.pone.0004944
Mishra, R. R., & Nath, G. (2020). Detection Of bacteriophages against Eskape group of nosocomial pathogens from Ganga River water during community bath at various rituals: Since 2013–2019. Journal of Applied Pharmaceutical Sciences and Research., 5, 7.
Nafarrate, I., Mateo, E., Amárita, F., de Marañón, I. M., & Lasagabaster, A. (2020). Efficient isolation of Campylobacter bacteriophages from chicken skin, analysis of several isolation protocols. Food Microbiology, 90, 103486. https://doi.org/10.1016/j.fm.2020.103486
Nasser, A., Azizian, R., Tabasi, M., Khezerloo, J. K., Heravi, F. S., Kalani, M. T., et al. (2019). Specification of bacteriophage isolated against clinical methicillin-resistant Staphylococcus Aureus. Osong Public Health and Research Perspectives, 10(1), 20–24. https://doi.org/10.24171/j.phrp.2019.10.1.05
Nir-Paz, R., Gelman, D., Khouri, A., Sisson, B. M., Fackler, J., Alkalay-Oren, S., et al. (2019). Successful treatment of antibiotic-resistant, poly-microbial bone infection with bacteriophages and antibiotics combination. Clinical Infectious Diseases, 69(11), 2015–2018. https://doi.org/10.1093/cid/ciz222
Nobrega, F. L., Vlot, M., de Jonge, P. A., Dreesens, L. L., Beaumont, H. J. E., Lavigne, R., et al. (2018). Targeting mechanisms of tailed bacteriophages. Nature Reviews Microbiology, 16(12), 760–773. https://doi.org/10.1038/s41579-018-0070-8
Oechslin, F. (2018). Resistance development to bacteriophages occurring during bacteriophage therapy. Viruses, 10(7), 351. https://doi.org/10.3390/v10070351
Oh, H. K., Jo, J. H., Hwang, Y. J., & Myung, H. (2020). Complete genome sequence of a novel bacteriophage, ATCEA85, infecting Enterobacter aerogenes. Archives of Virology, 165(10), 2397–2400. https://doi.org/10.1007/s00705-020-04751-y
Ong, S. P., Azam, A. H., Sasahara, T., Miyanaga, K., & Tanji, Y. (2020). Characterization of Pseudomonas lytic phages and their application as a cocktail with antibiotics in controlling Pseudomonas aeruginosa. Journal of Bioscience and Bioengineering, 129(6), 693–699. https://doi.org/10.1016/j.jbiosc.2020.02.001
Onsea, J., Soentjens, P., Djebara, S., Merabishvili, M., Depypere, M., Spriet, I., et al. (2019). Bacteriophage application for difficult-to-treat musculoskeletal infections: Development of a standardized multidisciplinary treatment protocol. Viruses. https://doi.org/10.3390/v11100891
Patil, A., Banerji, R., Kanojiya, P., Koratkar, S., & Saroj, S. (2021). Bacteriophages for ESKAPE: Role in pathogenicity and measures of control. Expert Review of Anti-Infective Therapy. https://doi.org/10.1080/14787210.2021.1858800
Peng, C., Hanawa, T., Azam, A. H., LeBlanc, C., Ung, P., Matsuda, T., et al. (2019). Silviavirus phage ɸMR003 displays a broad host range against methicillin-resistant Staphylococcus aureus of human origin. Applied Microbiology and Biotechnology, 103(18), 7751–7765. https://doi.org/10.1007/s00253-019-10039-2
Petrovic Fabijan, A., Lin, R. C. Y., Ho, J., Maddocks, S., Ben Zakour, N. L., Iredell, J. R., et al. (2020). Safety of bacteriophage therapy in severe Staphylococcus aureus infection. Nature Microbiology, 5(3), 465–472. https://doi.org/10.1038/s41564-019-0634-z
Petsong, K., Benjakul, S., & Vongkamjan, K. (2020). Optimization of wall material for phage encapsulation via freeze-drying and antimicrobial efficacy of microencapsulated phage against Salmonella. Journal of Food Science and Technology. https://doi.org/10.1007/s13197-020-04705-x
Rahmat Ullah, S., Andleeb, S., Raza, T., Jamal, M., & Mehmood, K. (2017). Effectiveness of a lytic phage SRG1 against vancomycin-resistant Enterococcus faecalis in compost and soil. BioMed Research International, 2017, 1–8. https://doi.org/10.1155/2017/9351017
Segall, A. M., Roach, D. R., & Strathdee, S. A. (2019). Stronger together? Perspectives on phage-antibiotic synergy in clinical applications of phage therapy. Current Opinion in Microbiology, 51, 46–50. https://doi.org/10.1016/j.mib.2019.03.005
Shahin, K., & Bouzari, M. (2018). Bacteriophage application for biocontrolling Shigella flexneri in contaminated foods. Journal of Food Science and Technology, 55(2), 550–559. https://doi.org/10.1007/s13197-017-2964-2
Suay-García, B., & Pérez-Gracia, M. T. (2017). Drug-resistant Neisseria gonorrhoeae: Latest developments. European Journal of Clinical Microbiology & Infectious Diseases, 36(7), 1065–1071. https://doi.org/10.1007/s10096-017-2931-x
Sulakvelidze, A., Alavidze, Z., & Morris, J. G. (2001). Bacteriophage therapy. Antimicrobial Agents and Chemotherapy, 45(3), 649–659. https://doi.org/10.1128/AAC.45.3.649-659.2001
Tabassum, R., Shafique, M., Khawaja, K. A., Alvi, I. A., Rehman, Y., Sheik, C. S., et al. (2018). Complete genome analysis of a Siphoviridae phage TSK1 showing biofilm removal potential against Klebsiella pneumoniae. Scientific Reports, 8(1), 17904. https://doi.org/10.1038/s41598-018-36229-y
Tacconelli, E., Carrara, E., Savoldi, A., Harbarth, S., Mendelson, M., Monnet, D. L., et al. (2018). Discovery, research, and development of new antibiotics: The WHO priority list of antibiotic-resistant bacteria and tuberculosis. The Lancet Infectious Diseases, 18(3), 318–327. https://doi.org/10.1016/S1473-3099(17)30753-3
Taha, O. A., Connerton, P. L., Connerton, I. F., & El-Shibiny, A. (2018). Bacteriophage ZCKP1: A potential treatment for Klebsiella pneumoniae isolated from diabetic foot patients. Frontiers in Microbiology. https://doi.org/10.3389/fmicb.2018.02127
Tkhilaishvili, T., Wang, L., Tavanti, A., Trampuz, A., & Di Luca, M. (2020). Antibacterial efficacy of two commercially available bacteriophage formulations, staphylococcal bacteriophage and PYO bacteriophage, against methicillin-resistant Staphylococcus aureus: Prevention and eradication of biofilm formation and control of a syst. Frontiers in Microbiology. https://doi.org/10.3389/fmicb.2020.00110
Vasilyev, A. O., Sazonova, N. A., Melnikov, V. D., Gabdullin, A. F., Zaitsev, A. V., Shiryaev, A. A., et al. (2020). The experience of using a bacteriophages-based complex antibacterial and analgesic drug in gel formulation in women who underwent various instrumental and diagnostic and treatment interventions. Gynecology, 22(3), 42–48. https://doi.org/10.26442/20795696.2020.3.200199
Vukotic, G., Obradovic, M., Novovic, K., Di Luca, M., Jovcic, B., Fira, D., et al. (2020). Characterization, antibiofilm, and depolymerizing activity of two phages active on carbapenem-resistant Acinetobacter baumannii. Frontiers in Medicine. https://doi.org/10.3389/fmed.2020.00426
Wang, L., Tkhilaishvili, T., Bernal Andres, B., Trampuz, A., & Gonzalez Moreno, M. (2020). Bacteriophage–antibiotic combinations against ciprofloxacin/ceftriaxone-resistant Escherichia coli in vitro and in an experimental Galleria mellonella model. International Journal of Antimicrobial Agents, 56(6), 106200. https://doi.org/10.1016/j.ijantimicag.2020.106200
Wang, Z., Zheng, P., Ji, W., Fu, Q., Wang, H., Yan, Y., & Sun, J. (2016). SLPW: A virulent bacteriophage targeting methicillin-resistant Staphylococcus aureus in vitro and in vivo. Frontiers in Microbiology. https://doi.org/10.3389/fmicb.2016.00934
Wilson, D. N., Hauryliuk, V., Atkinson, G. C., & O’Neill, A. J. (2020). Target protection as a key antibiotic resistance mechanism. Nature Reviews Microbiology, 18(11), 637–648. https://doi.org/10.1038/s41579-020-0386-z
Yelin, I., & Kishony, R. (2018). Antibiotic resistance. Cell, 172(5), 1136-1136.e1. https://doi.org/10.1016/j.cell.2018.02.018
Yen, M., Cairns, L. S., & Camilli, A. (2017). A cocktail of three virulent bacteriophages prevents Vibrio cholerae infection in animal models. Nature Communications, 8(1), 14187. https://doi.org/10.1038/ncomms14187
Zhao, J., Zhang, Z., Tian, C., Chen, X., Hu, L., Wei, X., et al. (2019). Characterizing the biology of lytic bacteriophage vB_EaeM_φEap-3 infecting multidrug-resistant Enterobacter aerogenes. Frontiers in Microbiology. https://doi.org/10.3389/fmicb.2019.00420
Zhou, W., Feng, Y., & Zong, Z. (2018). Two new lytic bacteriophages of the myoviridae family against carbapenem-resistant Acinetobacter baumannii. Frontiers in Microbiology. https://doi.org/10.3389/fmicb.2018.00850
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Kaur, G., Agarwal, R. & Sharma, R.K. Bacteriophage Therapy for Critical and High-Priority Antibiotic-Resistant Bacteria and Phage Cocktail-Antibiotic Formulation Perspective. Food Environ Virol 13, 433–446 (2021). https://doi.org/10.1007/s12560-021-09483-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12560-021-09483-z